Insider Transactions in Q1 2022 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2022
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
44,084
-1.85%
|
$1,102,100
$25.32 P/Share
|
|
Mar 24
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,956
-1.05%
|
$223,900
$25.32 P/Share
|
|
Mar 24
2022
|
Nicole Lambert Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,347
-1.07%
|
$133,675
$25.32 P/Share
|
|
Mar 24
2022
|
Jayne B. Hart Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,641
-0.99%
|
$91,025
$25.32 P/Share
|
|
Mar 24
2022
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,666
-0.57%
|
$66,650
$25.32 P/Share
|
|
Mar 24
2022
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,842
-1.57%
|
$71,050
$25.32 P/Share
|
|
Mar 22
2022
|
Paul J Diaz President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
173,144
+12.58%
|
-
|
|
Mar 22
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,866
+7.89%
|
-
|
|
Mar 22
2022
|
Mark Verratti Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,238
+7.54%
|
-
|
|
Mar 22
2022
|
Nicole Lambert Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,665
+11.81%
|
-
|
|
Mar 22
2022
|
Jayne B. Hart Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,238
+9.41%
|
-
|
|
Mar 22
2022
|
Kevin Richard Haas Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,238
+17.44%
|
-
|
|
Mar 22
2022
|
Margaret Ancona SVP, Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
9,754
+20.79%
|
-
|
|
Mar 22
2022
|
Eric Santa Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,238
+24.37%
|
-
|
|
Mar 22
2022
|
Pamela Wong Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,353
+22.86%
|
-
|
|
Feb 28
2022
|
Jayne B. Hart Officer |
SELL
Open market or private sale
|
Direct |
10,500
-3.06%
|
$262,500
$25.0 P/Share
|
|
Feb 28
2022
|
Jayne B. Hart Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+2.96%
|
$241,500
$23.98 P/Share
|
|
Feb 25
2022
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
2,594
-8.65%
|
$62,256
$24.69 P/Share
|
|
Feb 25
2022
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
865
-1.19%
|
$20,760
$24.69 P/Share
|
|
Feb 18
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,180
-2.76%
|
$279,500
$25.69 P/Share
|
|
Feb 16
2022
|
Paul J Diaz President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
234,271
+18.52%
|
-
|
|
Feb 16
2022
|
Mark Verratti Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,616
+9.45%
|
-
|
|
Feb 16
2022
|
Nicole Lambert Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,295
+16.58%
|
-
|
|
Feb 16
2022
|
Jayne B. Hart Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,520
+10.53%
|
-
|
|
Feb 16
2022
|
Kevin Richard Haas Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,520
+21.17%
|
-
|
|
Feb 16
2022
|
Eric Santa Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,052
+37.28%
|
-
|
|
Feb 16
2022
|
Pamela Wong Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,072
+37.27%
|
-
|
|
Feb 16
2022
|
Richard Bryan Riggsbee Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,009
+10.6%
|
-
|